TORONTO, May 15, 2023 /CNW/ – Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) (“Auxly” or the “Company“) today released its financial results for the three months ended March 31, 2023. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares“) and per Share amounts.

Q1 2023 Highlights

• Total net revenues of $24.0 million in Q1 2023, an increase of $1.3 million or 6% compared to the same period in 2022;
• The Company achieved the first quarter of positive Adjusted EBITDA in its history;
• Retained the #5 LP position in Canada with 5.7% share of market and continued to improve sales of Cannabis 1.0 products, finishing the quarter with 4.6% share of market up from 3.7% in the previous quarter¹;
• The Cost of Finished Cannabis Inventory Sold Margin was 37% during the quarter, increasing from 23% during the first quarter of 2022 and 30% from the fourth quarter of 2022;
• Cash from continuing operating activities was $3.2 million during the current quarter, as compared to a use of cash of $7.0 million during the first quarter of 2022.

Read full release on Newswire here.

Auxly Financials and Filings.

TORONTO, March 31, 2023 /CNW/ – Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) (“Auxly” or the “Company“) today released its financial results for the three and twelve months ended December 31, 2022. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares“) and per Share amounts.

2022 Highlights

• Total net revenues of $94.4 million in 2022, an increase of $10.6 million or 13% compared to 2021;
• Made significant improvements to Adjusted EBITDA in the fourth quarter to negative $0.8 million, due to improved margins and lower SG&A, with momentum continuing into 2023;
• Fourth quarter total net revenues of $24.7 million, approximately $4.6 million lower than the same period in 2021, however $4.9 million or 20% greater than Q3 2022;
• Retained the #1 LP position in Canada for Cannabis 2.0 product sales for the third consecutive year, while improving sales of dried flower and pre-roll products, exiting the year with positive momentum as the #5 LP¹ by share of market;
• Successfully integrated Auxly Leamington and continuously improved product quality during 2022; and leveraged Leamington’s large-scale cultivation to introduce new successful strains to the market while continuing to drive down costs to become one of the lowest cost facilities in the country;
• Rationalized assets and product SKUs to improve financial performance and used non-core asset sale proceeds to further strengthen the balance sheet;
• Recorded non-cash impairment of approximately $25.7M related to the closure of Auxly Annapolis and Auxly Annapolis OG cultivation facilities during Q1 of 2022 and $45 million in the third quarter of 2022 related to impairment of goodwill and other assets.

Read full release on Newswire here.

Auxly Financials and Filings.

TORONTO, Ontario, November 14, 2022 – Auxly Cannabis Group Inc. (TSX ‐ XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”) today released its financial results for the three and nine months ended September 30, 2022. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts.

Q3 2022 Highlights

 —  Total net revenues from sale of adult use cannabis in Canada of $19.8 million for the three months ended September 30, 2022, a 19% decrease from the same period last year and a 28% increase year-to-date;

 —  SG&A declined approximately 11% from the previous quarter as the Company continues to focus its efforts on reducing costs;

 —  Adjusted EBITDA was negative $5.8 million, an improvement of $0.3 million as compared to the same period last year;

 —  Auxly Leamington continues to contribute to positive gross margins through low‐cost cultivation and increased yields;

 —  Continues to rank among the top 10 LPs in Canada by total recreational retail sales as the Company continues to launch new and exciting cannabis products to the Canadian market.

Read full release on GlobeNewswire here.

Auxly Financials and Filings.